AU4330685A – Cephems, carbacephems and oxacephmes derivatives
– Google Patents
AU4330685A – Cephems, carbacephems and oxacephmes derivatives
– Google Patents
Cephems, carbacephems and oxacephmes derivatives
Info
Publication number
AU4330685A
AU4330685A
AU43306/85A
AU4330685A
AU4330685A
AU 4330685 A
AU4330685 A
AU 4330685A
AU 43306/85 A
AU43306/85 A
AU 43306/85A
AU 4330685 A
AU4330685 A
AU 4330685A
AU 4330685 A
AU4330685 A
AU 4330685A
Authority
AU
Australia
Prior art keywords
oxacephmes
cephems
carbacephems
derivatives
oxacephmes derivatives
Prior art date
1984-06-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU43306/85A
Other versions
AU576588B2
(en
Inventor
Masahiko Fujino
Masahiro Kondo
Akio Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1984-06-07
Filing date
1985-06-03
Publication date
1985-12-12
1984-06-07
Priority claimed from PCT/JP1984/000295
external-priority
patent/WO1986000070A1/en
1985-04-01
Priority claimed from PCT/JP1985/000155
external-priority
patent/WO1986005787A1/en
1985-06-03
Application filed by Takeda Chemical Industries Ltd
filed
Critical
Takeda Chemical Industries Ltd
1985-12-12
Publication of AU4330685A
publication
Critical
patent/AU4330685A/en
1988-09-01
Application granted
granted
Critical
1988-09-01
Publication of AU576588B2
publication
Critical
patent/AU576588B2/en
2005-06-03
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
C07D501/14—Compounds having a nitrogen atom directly attached in position 7
C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
C07D463/16—Nitrogen atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
C07D463/16—Nitrogen atoms
C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
Y02P20/00—Technologies relating to chemical industry
Y02P20/50—Improvements relating to the production of bulk chemicals
Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
AU43306/85A
1984-06-07
1985-06-03
Cephems, carbacephems and oxacephmes derivatives
Ceased
AU576588B2
(en)
Applications Claiming Priority (4)
Application Number
Priority Date
Filing Date
Title
WOJP8400295
1984-06-07
PCT/JP1984/000295
WO1986000070A1
(en)
1984-06-07
1984-06-07
Cephem compounds
PCT/JP1985/000155
WO1986005787A1
(en)
1985-04-01
1985-04-01
Antibacterial compounds
WOJP8500155
1985-04-01
Publications (2)
Publication Number
Publication Date
AU4330685A
true
AU4330685A
(en)
1985-12-12
AU576588B2
AU576588B2
(en)
1988-09-01
Family
ID=26425045
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU43306/85A
Ceased
AU576588B2
(en)
1984-06-07
1985-06-03
Cephems, carbacephems and oxacephmes derivatives
Country Status (15)
Country
Link
US
(1)
US4665065A
(en)
EP
(1)
EP0164113B1
(en)
KR
(1)
KR920004823B1
(en)
AU
(1)
AU576588B2
(en)
CA
(1)
CA1264052A
(en)
DE
(1)
DE3577707D1
(en)
DK
(1)
DK256085A
(en)
ES
(2)
ES8609343A1
(en)
FI
(1)
FI852289L
(en)
GR
(1)
GR851384B
(en)
HU
(1)
HU194894B
(en)
NO
(1)
NO852294L
(en)
NZ
(1)
NZ212320A
(en)
PH
(1)
PH22107A
(en)
PT
(1)
PT80595B
(en)
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU617154B2
(en)
*
1988-03-09
1991-11-21
Fujisawa Pharmaceutical Co., Ltd.
New cephem compounds and processes for preparation thereof
Families Citing this family (13)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4788185A
(en)
*
1984-04-23
1988-11-29
Takeda Chemical Industries, Ltd.
Cephalosporin compounds
ATE89826T1
(en)
*
1985-03-01
1993-06-15
Takeda Chemical Industries Ltd
ANTIBACTERIAL COMPOUNDS, THEIR PREPARATION AND USE.
DE3688477T2
(en)
*
1985-03-01
1993-09-16
Takeda Chemical Industries Ltd
ANTIBACTERIAL CONNECTIONS, THEIR PRODUCTION AND USE.
DE3687200T2
(en)
*
1985-09-03
1993-05-27
Otsuka Kagaku Kk
CEPHALOSPORINE DERIVATIVES.
US4826834A
(en)
*
1985-09-27
1989-05-02
Takeda Chemical Industries, Ltd.
Cephem compounds
US4760140A
(en)
*
1986-10-20
1988-07-26
American Cyanamid Company
3-substituted-7-[5-substituted-2-thiazolyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid, diphenylmethyl esters
CA1293719C
(en)
*
1986-09-22
1991-12-31
Takao Takaya
Cephem compounds and processes for preparation thereof
US5019571A
(en)
*
1988-01-25
1991-05-28
Eli Lilly And Company
1-carbacephalosporin antibiotics
DE3803169A1
(en)
*
1988-02-03
1989-08-17
Bayer Ag
SS LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AND IN MEDICINAL PRODUCTS
US5173485A
(en)
*
1988-03-09
1992-12-22
Fujisawa Pharmaceutical Company, Ltd.
Cephem compounds
US5215982A
(en)
*
1989-11-10
1993-06-01
Fujisawa Pharmaceutical Co., Ltd.
Cephem compounds
KR930009796B1
(en)
*
1991-05-25
1993-10-11
주식회사 대웅제약
Cephalosporin derivatives
WO1998000159A1
(en)
*
1996-06-28
1998-01-08
Oxigene, Inc.
Useful formulations of acid addition salt drugs
Family Cites Families (14)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4024133A
(en)
*
1971-05-14
1977-05-17
Glaxo Laboratories Limited
7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins
US4033950A
(en)
*
1971-05-14
1977-07-05
Glaxo Laboratories Limited
3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
DK154939C
(en)
*
1974-12-19
1989-06-12
Takeda Chemical Industries Ltd
METHOD OF ANALOGUE FOR THE PREPARATION OF THIAZOLYLACETAMIDO-CEPHEM COMPOUNDS OR PHARMACEUTICAL ACCEPTABLE SALTS OR ESTERS THEREOF
GR63088B
(en)
*
1976-04-14
1979-08-09
Takeda Chemical Industries Ltd
Preparation process of novel cephalosporins
DE2714880A1
(en)
*
1977-04-02
1978-10-26
Hoechst Ag
CEPHEMDER DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
AR229883A1
(en)
*
1978-05-26
1983-12-30
Glaxo Group Ltd
PROCEDURE FOR THE PREPARATION OF ANTIBIOTIC (6R, 7R) -7 – ((Z) -2- (2-AMINOTIAZOL-4-IL) -2- (2-CARBOXIPROP-2-OXIIMINO) -ACETAMIDO) -3- (1 -PIRIDINOMETIL) -CEF-3-EM-4-CARBOXYLATE
GB2037281B
(en)
*
1978-11-15
1983-01-19
Glaxo Group Ltd
7( -(2-amino-4-thiozolyl)-2-hydroximino-acetanuds)-cephalosporins
ES511101A0
(en)
*
1981-04-03
1983-05-01
Fujisawa Pharmaceutical Co
“PROCEDURE TO PREPARE A NEW CEFEM COMPOUND”.
US4501739A
(en)
*
1982-01-19
1985-02-26
Eli Lilly And Company
Thieno and furopyridinium-substituted cephalosporins
US4500526A
(en)
*
1982-06-28
1985-02-19
Bristol-Myers Company
Cephalosporin derivatives
DE3336757A1
(en)
*
1983-10-08
1985-04-25
Hoechst Ag, 6230 Frankfurt
CEPHALOSPORINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION
GB2148289B
(en)
*
1983-10-17
1987-09-23
Lilly Co Eli
3-bicyclicpyridinium-methyl cephalosporins
GB8401093D0
(en)
*
1984-01-16
1984-02-15
Fujisawa Pharmaceutical Co
Cephem compounds
NO165842C
(en)
*
1984-04-23
1991-04-17
Takeda Chemical Industries Ltd
ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE CEFEM COMPOUNDS.
1985
1985-05-29
PH
PH32333A
patent/PH22107A/en
unknown
1985-05-30
US
US06/739,440
patent/US4665065A/en
not_active
Expired – Lifetime
1985-06-03
AU
AU43306/85A
patent/AU576588B2/en
not_active
Ceased
1985-06-05
EP
EP85106979A
patent/EP0164113B1/en
not_active
Expired – Lifetime
1985-06-05
ES
ES543932A
patent/ES8609343A1/en
not_active
Expired
1985-06-05
PT
PT80595A
patent/PT80595B/en
unknown
1985-06-05
DE
DE8585106979T
patent/DE3577707D1/en
not_active
Expired – Fee Related
1985-06-06
HU
HU852256A
patent/HU194894B/en
not_active
IP Right Cessation
1985-06-06
NO
NO852294A
patent/NO852294L/en
unknown
1985-06-06
NZ
NZ212320A
patent/NZ212320A/en
unknown
1985-06-06
GR
GR851384A
patent/GR851384B/el
unknown
1985-06-06
DK
DK256085A
patent/DK256085A/en
not_active
Application Discontinuation
1985-06-06
CA
CA000483303A
patent/CA1264052A/en
not_active
Expired
1985-06-07
KR
KR1019850004012A
patent/KR920004823B1/en
not_active
IP Right Cessation
1985-06-07
FI
FI852289A
patent/FI852289L/en
not_active
Application Discontinuation
1986
1986-01-21
ES
ES551064A
patent/ES8800240A1/en
not_active
Expired
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU617154B2
(en)
*
1988-03-09
1991-11-21
Fujisawa Pharmaceutical Co., Ltd.
New cephem compounds and processes for preparation thereof
Also Published As
Publication number
Publication date
ES551064A0
(en)
1987-11-01
FI852289L
(en)
1985-12-08
ES8800240A1
(en)
1987-11-01
HUT41034A
(en)
1987-03-30
HU194894B
(en)
1988-03-28
EP0164113B1
(en)
1990-05-16
PT80595B
(en)
1987-04-21
EP0164113A3
(en)
1987-01-28
DK256085A
(en)
1985-12-08
ES543932A0
(en)
1986-08-16
FI852289A0
(en)
1985-06-07
NZ212320A
(en)
1988-09-29
KR920004823B1
(en)
1992-06-18
PH22107A
(en)
1988-06-01
DK256085D0
(en)
1985-06-06
AU576588B2
(en)
1988-09-01
KR860000302A
(en)
1986-01-27
ES8609343A1
(en)
1986-08-16
GR851384B
(en)
1985-11-25
CA1264052A
(en)
1989-12-27
EP0164113A2
(en)
1985-12-11
PT80595A
(en)
1985-07-01
NO852294L
(en)
1985-12-09
DE3577707D1
(en)
1990-06-21
US4665065A
(en)
1987-05-12
Similar Documents
Publication
Publication Date
Title
AU1117788A
(en)
1988-07-28
Benzoxazone derivatives
AU577855B2
(en)
1988-10-06
Ammotetralin derivatives
AU4325485A
(en)
1985-12-05
Aminoalkylphenoxy derivatives
AU576924B2
(en)
1988-09-08
2-piperizino-pteridine derivatives
AU576588B2
(en)
1988-09-01
Cephems, carbacephems and oxacephmes derivatives
AU5131685A
(en)
1986-07-17
Aminoacyllabdane derivatives
AU573032B2
(en)
1988-05-26
Carbamoylimidazole derivatives
AU572279B2
(en)
1988-05-05
Hydroxy-4-2h-1-benzothiopyran-2-one derivatives
AU4343885A
(en)
1985-12-12
Indole – tetrahydropyridyl derivatives
AU3797485A
(en)
1985-08-01
Azolyl-aryl-alkanol derivatives
AU573334B2
(en)
1988-06-02
Chartreusin derivatives
AU570553B2
(en)
1988-03-17
Tetrahydroquinolin-1-yl- carbonylimidazole derivatives
AU552119B2
(en)
1986-05-22
2-oxindole-1-carboxamide derivatives
AU4901285A
(en)
1986-05-01
2 – cyanobenzimidazole derivatives
AU577393B2
(en)
1988-09-22
Apovincamine or vincamine derivatives
AU4106085A
(en)
1985-10-17
2 – oxoindole derivatives
AU4354385A
(en)
1985-11-28
Cephalosporin derivatives
AU4045585A
(en)
1986-01-30
Sulphamoylguanidine derivatives
AU3977285A
(en)
1985-09-19
Carboxyalkyldipeptide derivatives
AU572278B2
(en)
1988-05-05
Eburnane derivatives
AU5156585A
(en)
1986-07-03
N-acyl-n-isopropylglycine derivatives
AU4594285A
(en)
1986-02-13
Aminoalkylpenem derivatives
AU4045485A
(en)
1985-10-03
Thiatriazine derivatives
AU4085185A
(en)
1985-10-10
1-ph-3-sulfinyl-indole derivatives
AU557332B2
(en)
1986-12-18
Cephalosporin derivatives
None